McDermott Will & Schulte has advised Sensorion, a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, on its €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline.

The McDermott Will & Schulte team comprised:

• Emmanuelle Trombe, partner, on Life Sciences aspects
• Bertrand Delafaye, partner, Henri Nalbandyan and Agathe Bourdillon, associates, on Capital Markets aspects

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.